$591 | SAVE $104 | Single User
$2423 | SAVE $427 | Site License
$4803 | SAVE $847 | Global License

Inside China’s Pharma Sales Force – insights from the frontline

Inside China’s Pharma Sales Force – insights from the frontline
[Lowest Price Guaranteed: $591]

Published by FirstWord Pharma: 01 Jul 2013 | 49 | In Stock



In 2011, China’s pharmaceutical sales force exceeded that of the U.S. for the first time. However, very little data is available on China’s sales operations and tactics. FirstWord’s new report sheds light on how Pharma is using its still-expanding Chinese sales force, with exclusive insights from sales managers at multinational and domestic companies

China’s economy is one of the fastest growing in the world, and its pharmaceutical industry is also experiencing extremely rapid growth. Just as in the U.S., Japan, and Europe, China’s pharma industry is also being transformed – with moves towards universal healthcare coverage, more ethical practices, and greater use of digital channels. However, China’s unique geography, government, and culture mean that local knowledge is essential to bring an understanding of what is happening on the ground.

In creating this much-needed report, FirstWord interviewed seven regional and district sales managers at western pharmaceutical companies operating in China. FirstWord also conducted interviews with regional and national sales managers at two Chinese companies to ascertain the differences in the way local and multinational companies operate their sales teams.

Along with exclusive research, this report is packed with useful information about China’s pharmaceutical industry, including an overview of the key Pharma companies investing in China, a city tiers reference, and a China-specific definition of a Key Opinion Leader.

Whether or not your company has a presence in China, understanding the Chinese sales force gives you a significant competitive edge. Download this illuminating new report today!


Report Highlights

  • Details of how promotional spending in China is changing

  • Guide to how pharmaceutical sales teams are structured in China – including what percentage of reps deal with physicians vs. other stakeholders

  • Insight into how sales reps in China conduct meetings with physicians, what information they share, and how they record the interaction

  • Comparison of multinational pharmaceutical company and local company sales cultures

  • Profile of the key characteristics and tactics of a successful sales rep in China

  • Highlights

    The benefits of this report

    FirstWord’s new report fills that significant knowledge gap with exclusive statistics, trends, and expert commentary that comes straight from the source. Now you can compare your sales activities with those of other multinational and local companies in China, understand the current commercial environment in China, and stay ahead with insights into how it is expected to change. With this concise report, you will:

  • Understand how to structure a sales force across China

  • Learn the key characteristics of a successful sales rep in China (and recruit accordingly)

  • Know how often your sales reps in China should visit physicians, and how many doctors should be on their list

  • Learn how promotional spending in China is changing, and benchmark spending against the industry average

  • Be aware of significant opportunities for growth and greater efficiency that still exist in the Chinese market

  • Puchase Reasons

    Selected quotes from the report

    “In China, there is a social aspect to the relationship between the reps and the physicians, where very often personal free time is used to speak about the pharmaceutical products outside of the hospital setting.” Delphine Perridy, country manager China – regional director SEA, Cegedim Strategic Data

    “In order to achieve a full cover of the ‘viable market’ you need between 80 and 400 distributors/wholesalers if you are to avoid having products going through one or two layers of distribution for more hospitals. The smaller the number of primary distributors that the company works with, the larger the number of total suppliers of their products as they will have a lack of control of the ‘route to market’.” Anonymous consultant

    “We have a sales representative to see physicians at every level of the hospital. Above them we have key account managers and a regional manager. We also have a government affairs department which deals with government officials.” District Sales Manager from western pharma company

    Table of Contents
    for Inside China’s Pharma Sales Force – insights from the frontline

    • 1.Executive summary


      3.Methodology and acknowledgements

      4.FirstWord would like to thank them for their input into this report without which it would not have been possible.

      5.The pharmaceutical industry in China

      6.Promotional activities in China

      7.The pharmaceutical sales force in China

      7.1.Sales force structure

      7.2.Engaging with customers

      7.2.1.Key opinion leader management in China

      7.3.Profile of a sales rep in China


    Additional Details


    FirstWord Pharma

    Publisher Information


    49 |

    Number of Pages


    Report Format


    FirstWord Pharma Reports

    Related Reports

    TitleDate PublishedPrice fromMore Details
    SAVE 15% today! Global Auto Dimming Mirror Market Size study with COVID-19 impact, by Fuel (Ice, BEV and Others (Hybrid)), by Application (Outer Rear-View Dimming Mirror and Inside Rear-View Dimming Mirror), by Vehicle type (Light Commercial Vehicles and Passenger Vehicles), Functionality (Connected Auto Dimming Mirror and Non-Connected Auto Dimming Mirror) and Regional Forecasts 2020-2027
    Global Auto Dimming Mirror Market is valued approximately USD 1.80 Billion in 2019 and is anticipate...
    10 Jul 2020 by Bizwit Research and Consulting USD $4,208 (normally
    USD $4,951)
    More Info
    SAVE 15% today! Biophotonics Market by Application(See-through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors), Technology(In-vivo, In-vitro), End-use(Diagnostics, Therapeutic, Tests), & Geography - Global Forecast to 2020
    Emergence of nanotechnology and significant technological advancements in the field of biophotonics ...
    10 Nov 2015 by MarketsandMarkets USD $4,803 (normally
    USD $5,651)
    More Info
    SAVE 15% today! Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
    IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
    01 Jun 2012 by FirstWord Pharma USD $846 (normally
    USD $995)
    More Info

    This report is published by FirstWord Pharma

    Download Free Report Summary PDF

    Inside China’s Pharma Sales Force – insights from the frontline | Download PDF Summary

    Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

    Ordering Information

    Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

    Accepted Card Types


    Buy now using our secure payment system.

    We Stock...